Breaking News Instant updates and real-time market news.

GLYC

GlycoMimetics

$12.36

-0.34 (-2.68%)

05:35
07/12/19
07/12
05:35
07/12/19
05:35

GlycoMimetics risk/reward 'highly favorable' into data, says Piper Jaffray

Piper Jaffray analyst Danielle Brill thinks there is a "substantial amount of evidence" that shows clear proof-of-efficacy of GlycoMimetics' rivipansel in the sickle cell disease population. As such, the analyst remains confident that the Phase 3 data expected this quarter will be positive. The stock's risk/reward is "highly favorable," with 70%-100% upside versus downside of 20%-25% on the readout, making GlycoMimetics "even more compelling ahead of the data," Brill tells investors in a research note. She reiterates an Overweight rating on the shares with a $20 price target.

  • 23

    Jul

  • 09

    Sep

GLYC GlycoMimetics
$12.36

-0.34 (-2.68%)

04/12/19
PIPR
04/12/19
INITIATION
Target $20
PIPR
Overweight
GlycoMimetics initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Danielle Brill started GlycoMimetics with an Overweight rating and $20 price target. The shares are undervalued considering the company has two Phase 3 assets in rivipansel and uproleselan with data for the former expected by the end of Q2, Brill tells investors in a research note. Rivipansel aims to reduce duration of sickle cell disease related pain crises and hospitalization times, the analyst points out. She views the drug as a $1.5B opportunity that is not fully priced into the stock. Brill sees "significant upside from two relatively de-risked programs."
05/13/19
PIPR
05/13/19
NO CHANGE
PIPR
Piper 'incrementally more bullish' on GlycoMimetics, Global Blood
After speaking to a practicing hematologist and emergency medicine doctor at a leading medical institution, Piper Jaffray analyst Danielle Brill is "incrementally more bullish" on both GlycoMimetics (GLYC) and Global Blood Therapeutics (GBT). The former has pivotal Phase 3 data with rivipansel expected in July and the latter is in the process of submitting a new drug application for voxelotor via the accelerated approval pathway, Brill tells investors in a research note. Further, the analyst says feedback from the expert reaffirmed her neutral outlook for Bluebird Bio's (BLUE) LentiGlobin. The hematologist expects rivipansel to be successful in the Phase 3 trial and anticipates use for most acute sickle cell disease crises requiring provider intervention, according to Brill. Further, she was surprised to hear how enthusiastic the expert was about voxelotor.
05/28/19
PIPR
05/28/19
NO CHANGE
PIPR
Piper more bullish on GlycoMimetics, Global Blood into upcoming catalysts
After surveying 25 sickle cell disease experts, Piper Jaffray analyst Danielle Brill is "incrementally more bullish" on both GlycoMimetics (GLYC) and Global Blood Therapeutics (GBT) into their upcoming catalysts. GlycoMimetics and partner Pfizer (PFE) have pivotal Phase 3 results with rivipansel, their pan-selectin inhibitor, reading out in July, Brill tells investors in a research note. And Global Blood Therapeutics is expected to complete its new drug application submission for voxelotor via the accelerated approval pathway and present full Phase 3 Hope trial data in June, adds the analyst. Following expert feedback, Brill remains confident for a successful Phase 3 outcome with rivipansel. She believes positive data will drive GlycoMimetics shares "meaningfully higher" in July. Further, the majority of the surveyed doctors believe voxelotor's hemolytic anemia benefit is clinically relevant and most expect accelerated approval based on these data, adds the analyst.
06/28/19
JEFF
06/28/19
NO CHANGE
Target $19
JEFF
Buy
GlycoMimetics shares could rally 50% on rivipansel data, says Jefferies
Pfizer (PFE) is expecting data from Phase 3 testing of rivipansel, a treatment for sickle cell patients experiencing vaso-occlusive crises, in the July/August timeframe, Jefferies analyst Biren Amin tells investors in a research note. Given that GlycoMimetics (GLYC) would receive royalties on worldwide sales, the stock may move 50% on positive data and drop 40% on a negative outcome, says the analyst. He believes that while the trial is difficult to predict, the design and the enrollment of younger patients "provide some confidence of a positive outcome." Amin keeps a Buy rating on GlycoMimetics shares with a $19 price target.

TODAY'S FREE FLY STORIES

SNE

Sony

$54.33

-1.44 (-2.58%)

10:35
07/16/19
07/16
10:35
07/16/19
10:35
Options
Sony put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

WFC

Wells Fargo

$46.55

-0.15 (-0.32%)

10:33
07/16/19
07/16
10:33
07/16/19
10:33
Hot Stocks
Breaking Hot Stocks news story on Wells Fargo »

Wells Fargo CFO says 38…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 12

    Oct

GCAP

Gain Capital

$4.54

0.51 (12.66%)

10:29
07/16/19
07/16
10:29
07/16/19
10:29
Hot Stocks
Gain Capital up 50c, or 12%, to $4.53 in early trading »

Contacts have indicated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

WFC

Wells Fargo

$46.88

0.18 (0.39%)

10:27
07/16/19
07/16
10:27
07/16/19
10:27
Hot Stocks
Breaking Hot Stocks news story on Wells Fargo »

Wells Fargo sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 12

    Oct

WFC

Wells Fargo

$46.88

0.18 (0.39%)

10:26
07/16/19
07/16
10:26
07/16/19
10:26
Hot Stocks
Wells Fargo sees FY19 NII down near 5% »

Management says auto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 12

    Oct

KMX

CarMax

$84.47

-4.31 (-4.85%)

10:25
07/16/19
07/16
10:25
07/16/19
10:25
Options
CarMax call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

EGHT

8x8, Inc.

$25.38

-0.24 (-0.94%)

, FIVN

Five9

$50.13

2.13 (4.44%)

10:25
07/16/19
07/16
10:25
07/16/19
10:25
Conference/Events
Stephens communications analysts to hold an analyst/industry conference call »

Communications Analysts,…

EGHT

8x8, Inc.

$25.38

-0.24 (-0.94%)

FIVN

Five9

$50.13

2.13 (4.44%)

LOGM

LogMeln

$76.20

-0.37 (-0.48%)

RNG

RingCentral

$124.44

1.13 (0.92%)

WORK

Slack Technologies

$34.84

0.06 (0.17%)

TWLO

Twilio

$147.01

1.655 (1.14%)

VG

Vonage

$12.82

0.03 (0.23%)

ZM

Zoom Video

$98.50

-1.26 (-1.26%)

GOOG

Alphabet

$1,150.69

0.3 (0.03%)

MSFT

Microsoft

$138.20

-0.74 (-0.53%)

AMZN

Amazon.com

$2,019.00

-2 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 18

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 27

    Oct

  • 13

    Nov

UBER

Uber

$44.49

-0.02 (-0.04%)

, LYFT

Lyft

$64.80

(0.00%)

10:22
07/16/19
07/16
10:22
07/16/19
10:22
Periodicals
Court says NYC can ban ads inside Uber, Lyft vehicles, Reuters reports »

Reversing a lower court…

UBER

Uber

$44.49

-0.02 (-0.04%)

LYFT

Lyft

$64.80

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

FCAU

Fiat Chrysler

$13.61

-0.565 (-3.99%)

, WORK

Slack Technologies

$34.75

-0.03 (-0.09%)

10:20
07/16/19
07/16
10:20
07/16/19
10:20
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

FCAU

Fiat Chrysler

$13.61

-0.565 (-3.99%)

WORK

Slack Technologies

$34.75

-0.03 (-0.09%)

BTE

Baytex Energy

$1.47

0.03 (2.08%)

TOWN

TowneBank

$26.85

(0.00%)

VET

Vermilion Energy

$21.76

-0.2 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 29

    Jul

  • 31

    Jul

  • 11

    Sep

HD

Home Depot

$218.16

-0.55 (-0.25%)

, SON

Sonoco

$64.48

-0.005 (-0.01%)

10:20
07/16/19
07/16
10:20
07/16/19
10:20
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

HD

Home Depot

$218.16

-0.55 (-0.25%)

SON

Sonoco

$64.48

-0.005 (-0.01%)

PH

Parker-Hannifin

$172.01

4.33 (2.58%)

FDS

FactSet

$281.22

-13.02 (-4.43%)

KMT

Kennametal

$35.09

0.295 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 18

    Jul

  • 01

    Aug

  • 06

    Aug

  • 12

    Aug

  • 20

    Aug

  • 20

    Aug

  • 17

    Oct

LH

LabCorp

$174.70

0.155 (0.09%)

, TKR

Timken

$48.61

0.92 (1.93%)

10:20
07/16/19
07/16
10:20
07/16/19
10:20
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

LH

LabCorp

$174.70

0.155 (0.09%)

TKR

Timken

$48.61

0.92 (1.93%)

FCX

Freeport McMoRan

$11.23

0.09 (0.81%)

WPM

Wheaton Precious Metals

$24.45

0.27 (1.12%)

OMF

OneMain Holdings

$35.07

1.135 (3.34%)

NOK

Nokia

$5.15

0.045 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 06

    Aug

  • 09

    Aug

  • 09

    Sep

10:20
07/16/19
07/16
10:20
07/16/19
10:20
General news
The June U.S. industrial production report tracked estimates »

The June U.S. industrial…

10:20
07/16/19
07/16
10:20
07/16/19
10:20
General news
The May U.S. business inventory report tracked estimates »

The May U.S. business…

RTN

Raytheon

$178.96

0.88 (0.49%)

10:19
07/16/19
07/16
10:19
07/16/19
10:19
Hot Stocks
Raytheon submits Lower Tier Air and Missile Defense Sensor proposal to U.S. Army »

Raytheon Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
07/16/19
07/16
10:17
07/16/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
07/16/19
07/16
10:16
07/16/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$26.70

(0.00%)

10:15
07/16/19
07/16
10:15
07/16/19
10:15
Periodicals
L Brands CEO says not aware of Jeffrey Epstein's behavior, WSJ reports »

In a memo to employees on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

IQ

iQIYI

$18.97

-0.52 (-2.67%)

10:15
07/16/19
07/16
10:15
07/16/19
10:15
Options
iQiyi put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVLO

Evelo Biosciences

$7.66

(0.00%)

10:13
07/16/19
07/16
10:13
07/16/19
10:13
Hot Stocks
Breaking Hot Stocks news story on Evelo Biosciences »

Evelo Biosciences Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

10:10
07/16/19
07/16
10:10
07/16/19
10:10
General news
U.S. July NAHB housing market index rebounded 1 point to 65 »

U.S. July NAHB housing…

10:10
07/16/19
07/16
10:10
07/16/19
10:10
General news
U.S. business inventories rose 0.3% in May with sales up 0.2% »

U.S. business inventories…

EVLO

Evelo Biosciences

$7.66

(0.00%)

10:08
07/16/19
07/16
10:08
07/16/19
10:08
Hot Stocks
Breaking Hot Stocks news story on Evelo Biosciences »

Evelo Biosciences Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

SPAR

Spartan Motors

$11.40

1.49 (15.04%)

, AMZN

Amazon.com

$2,023.41

2.41 (0.12%)

10:06
07/16/19
07/16
10:06
07/16/19
10:06
Recommendations
Craig-Hallum says Spartan order is from Amazon, boosts price target to $15 »

Craig-Hallum analyst…

SPAR

Spartan Motors

$11.40

1.49 (15.04%)

AMZN

Amazon.com

$2,023.41

2.41 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 25

    Jul

  • 06

    Aug

DISCA

Discovery

$32.33

-0.04 (-0.12%)

10:05
07/16/19
07/16
10:05
07/16/19
10:05
Options
Discovery call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

LAD

Lithia Motors

$118.88

-0.55 (-0.46%)

10:04
07/16/19
07/16
10:04
07/16/19
10:04
Hot Stocks
Lithia Motors appoints Tina Miller as SVP, CFO »

Lithia Motors announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.